The basal kinetic parameters of glycogen synthase in human myotube cultures are not affected by chronic high insulin exposure  by Gaster, M et al.
The basal kinetic parameters of glycogen synthase in human myotube
cultures are not a¡ected by chronic high insulin exposure
M. Gaster a;b;*, H.D. SchrÖder b, A. Handberg c, H. Beck-Nielsen a
a Department of Endocrinology, Odense University Hospital, DK-5000 Odense, Denmark
b Department of Pathology, Odense University Hospital, DK-5000 Odense, Denmark
c Department of Clinical Biochemistry, Aî rhus University Hospital, Aî rhus, Denmark
Received 10 January 2001; received in revised form 2 July 2001; accepted 23 July 2001
Abstract
There is no consensus regarding the results from in vivo and in vitro studies on the impact of chronic high insulin and/or
high glucose exposure on acute insulin stimulation of glycogen synthase (GS) kinetic parameters in human skeletal muscle.
The aim of this study was to evaluate the kinetic parameters of glycogen synthase activity in human myotube cultures at
conditions of chronic high insulin combined or not with high glucose exposure, before and after a subsequent acute insulin
stimulation. Acute insulin stimulation significantly increased the fractional activity (FV0:1) of GS, increased the sensitivity of
GS to the allosteric activator glucose 6-phosphate (A0:5) and increased the sensitivity of GS to its substrate UDPG (Km0:1)
when myotubes were precultured at low insulin with/without high glucose conditions. However, this effect of acute insulin
stimulation was abolished in myotubes precultured at high insulin with or without high glucose. Furthermore, we found
significant correlations between the fractional velocities FV0:1 of GS and Km0:1 (b=30.72, P6 0.0001), between FV0:1 and
A0:5 (b=30.82, P6 0.0001) and between Km0:1 and A0:5 values (b= 0.71, P6 0.0001). Our results show that chronic
exposure of human myotubes to high insulin with or without high glucose did not affect the basal kinetic parameters but
abolished the reactivity of GS to acute insulin stimulation. We suggest that insulin induced insulin resistance of GS is caused
by a failure of acute insulin stimulation to decrease A0:5 and Km0:1 in human skeletal muscle. ß 2001 Elsevier Science B.V.
All rights reserved.
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1. Introduction
Human satellite cell cultures are an important tool
for the investigation of skeletal muscle metabolism
[1]. A number of laboratories have used cultures of
human myotubes to study aspects of acquired or
genetic insulin resistance in skeletal muscle. Results
from previous studies of cultured human myotubes
have shown that the kinetic background for the acute
insulin stimulation of glycogen synthase (GS) seems
to be an increased sensitivity to glucose 6-phosphate
(G6P), an increased Vmax0:1 and an unchanged
Km0:1 [2]. However, Km values were not decreased
by increasing G6P concentrations from 0.1 to 10
mmol/l [2]. From the same studies it was concluded
[3,4] that human muscle cells precultured in high in-
sulin medium obtained a reduced sensitivity to sub-
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sequent acute insulin stimulation. Kinetic analyses
suggested that preculture of human myotubes in
high insulin medium conditions for 4 days increased
basal Km0:1 and Vmax0:1 values of GS, and abol-
ished further changes in these parameters by subse-
quent acute insulin stimulation [2]. This was taken to
indicate that acquired insulin resistance is based on
(a) increased basal values of Km0:1 and Vmax0:1 and
(b) an abolished e¡ect of acute insulin stimulation on
A0:5 and Vmax0:1.
Results from in vivo studies showed that the frac-
tional velocities (FV) of basal GS activities were
comparable in NIDDM and control subjects, and
that FV0:1 increased in both study groups following
acute insulin stimulation [5]. Moreover, basal A0:5
values were similar in control subjects and NIDDM
patients and decreased signi¢cantly in both groups
during a hyperinsulinaemic clamp [5]. The e¡ect of
acute and chronic insulin stimulation on Km of GS
has not been assessed in human skeletal muscles. In-
sulin resistance in vivo does not seem to be based
upon an altered basal state of GS or an abolished
e¡ect of acute insulin on A0:5. Thus, there is no con-
sensus regarding the results from in vivo and in vitro
studies of the e¡ect of acute insulin stimulation on
the kinetic parameters of GS in muscles derived from
a di¡erent metabolic background.
The aim of this study was to evaluate the kinetic
parameters of glycogen synthase activity at condi-
tions of chronic high insulin with or without high
glucose, before and after subsequent acute insulin
stimulation in an optimised human satellite cell mod-
el system [6].
2. Methods
2.1. Materials
Dulbecco’s modi¢ed Eagle’s medium (DMEM), fe-
tal calf serum (FCS), ultroser G, penicillin^strepto-
mycin^amphotericin B and trypsin were obtained
from Life Technology (UK). Uridine 5-diphosphate
(UDP)-[14C]glucose (10.63 GBq/mol) was obtained
from DuPont NEN (Boston, MA, USA). The pro-
tein assay kit was purchased from Bio-Rad (Copen-
hagen, Denmark). Glycogen, pepstatin A, leupeptin,
phenylmethylsulphonyl £uoride (PMFS), ECM gel
and anti-MY32 were purchased from Sigma (St.
Louis, MO, USA). Reagents for chemiluminescence
detection of immunoreactivity were from Pierce
(USA). Biotinylated goat anti-rabbit Ig, biotinylated
goat anti-mouse Ig, and horseradish peroxidase
(HRP) conjugated streptavidin were purchased
from Dako (Denmark). Insulin actrapid was from
Novo Nordisk (Bagsvaerd, Denmark).
2.2. Human study subjects
Ten healthy volunteers with normal fasting glucose
(range 4.9^5.4 mmol/l) and fasting insulin (range 29^
41 pmol/l) participated in the study. All subjects gave
written informed consent, and the local ethic com-
mittees of Funen and Vejle Community approved the
study. Muscle biopsies from vastus lateralis were per-
formed ad modum BergstrÖm [7].
2.3. Cell culture
Cell cultures were established as previously de-
scribed [6]. In brief, muscle tissue was minced,
washed and dissociated for 60 min by three treat-
ments with 0.05% trypsin^EDTA. The harvested cells
were pooled and FCS was added as protease inhib-
itor. The cells were seeded for upscaling on ECM gel
coated dishes after 30 min of preplating. Cell cultures
were established in DMEM medium supplemented
with 10% FCS, 50 U/ml penicillin, 50 Wg/ml strepto-
mycin, and 1.25 Wg/ml amphotericin B. After 24 h
cell debris and non-adherent cells were removed by
change of growth medium to DMEM supplemented
with 2% FCS, 2% ultroser G, 50 U/ml penicillin, 50
Wg/ml streptomycin, and 1.25 Wg/ml amphotericin B.
Cells were subcultured twice before ¢nal seeding in
100 mm petri dishes. At 75% con£uence the growth
medium was replaced by basal medium (DMEM
supplemented with 2% FCS, 50 U/ml penicillin, 50
Wg/ml streptomycin, 1.25 Wg/ml amphotericin B and
25 pmol/l insulin) in order to induce di¡erentiation.
After cell fusion (day 4) cultures were exposed for
4 days to the following medium conditions: (a) basal
medium (5.5 mmol/l glucose, 25 pmol/l insulin), (b)
high insulin medium (5.5 mmol/l glucose, 1 Wmol/l
insulin), (c) high glucose medium (20 mmol/l glucose,
25 pmol/l insulin) and (d) high insulin^glucose me-
dium (20 mmol/l glucose, 1 Wmol/l insulin). The cells
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were cultured in a humidi¢ed 5% CO2 atmosphere at
37‡C and medium was changed regularly every 2^3
days. All cultures were harvested after 8 days of on-
set of di¡erentiation. Cells were rinsed twice and in-
cubated for 1 h in basal medium followed by a 1 h
exposure to basal (5.5 mmol/l glucose, 25 pmol/l in-
sulin) or acute insulin stimulation (5.5 mmol/l glu-
cose, 1 Wmol/l insulin) and cell extracts obtained.
2.4. GS activity
The GS activity was measured as described by
Mandarino et al. [8]. Cells were washed three times
with ice-cold PBS and 700 Wl GS bu¡er (50 mmol/l
HEPES, 10 mmol/l EDTA, 100 mmol/l NaF,
5 mmol/l DTT, 1 Wmol/l leupeptin, 1 Wmol/l pepstatin
and 200 Wmol/l PMSF, pH 7.5) were added to each
petri dish. Cells were scraped from the dishes into
cryotubes, sonicated for 15 s twice at 4‡C (Sinirep
150, amplitude 14 Wm), frozen and stored at 380‡C.
Aliquots of sonicate were used for determination of
GS activity and protein. GS activity was determined
at 0.3 mmol/l UDP-glucose in parallel incubations
with 0, 0.05, 0.1, 1.0 and 10 mmol/l glucose 6-phos-
phate. The number of cultures studied under each
condition is given in parentheses in Tables 1 and 2.
GS activity is expressed as nanomoles of UDP-glu-
cose incorporated into glycogen per minute per milli-
gram of total protein. The speci¢c GS activity is
calculated as the above GS activity divided by the
amount of GS protein determined by Western blot-
ting and expressed as nanomoles of UDP-glucose
incorporated into glycogen per minute per OD GS
protein. FV0:1 is calculated as the mean of the ratios
of GS activities determined at 0.1 mmol/l G6P and
10 mmol/l G6P in the individual cultures. The G6P
Table 1
GS activity in cultures of human satellite cells
Medium (4 days) Basal (1 h) Acute insulin (1 h)
glucose/insulin 5.5 mmol/l/25 pmol/l 5.5 mmol/l/1 Wmol/l
5.5 mmol/l/25 pmol/l
0.1 mmol/l G6P 1.08 þ 0.18 (9) 1.40 þ 0.21 (10)*
10 mmol/l G6P 6.96 þ 1.18 (9) 7.54 þ 1.23 (10)
FV (0.1/10) (%) 13.20 þ 1.72 (9) 20.97 þ 2.23 (10)*
A0:5 0.74 þ 0.03 (9) 0.55 þ 0.08 (9)*
Hill coef. 1.01 þ 0.03 (9) 0.92 þ 0.03 (9)
5.5 mmol/l/1 Wmol/l
0.1 mmol/l G6P 1.18 þ 0.15 (9) 1.39 þ 0.19 (10)
10 mmol/l G6P 8.20 þ 1.01 (9) 8.99 þ 0.78 (10)
FV (0.1/10) (%) 15.48 þ 1.55 (9) 14.98 þ 1.35 (10)**
A0:5 0.73 þ 0.09 (8) 0.70 þ 0.09 (8)
Hill coef. 0.98 þ 0.01 (8) 0.94 þ 0.02 (8)
20 mmol/l/25 pmol/l
0.1 mmol/l G6P 0.95 þ 0.19 (8) 1.48 þ 0.20 (9)*
10 mmol/l G6P 8.36 þ 1.94 (8) 8.82 þ 0.99 (9)
FV (0.1/10) (%) 10.78 þ 0.82 (8)**;*** 16.20 þ 1.13 (9)*
A0:5 0.99 þ 0.09 (6)** 0.66 þ 0.07 (7)*
Hill coef. 1.00 þ 0.02 (6) 0.97 þ 0.03 (7)
20 mmol/l/1 Wmol/l
0.1 mmol/l G6P 1.07 þ 0.16 (9) 1.15 þ 0.19 (10)
10 mmol/l G6P 8.76 þ 0.89 (9) 8.58 þ 1.12 (10)
FV (1.0/10) (%) 11.79 þ 1.18 (9)22 13.20 þ 2.15 (10)**;2
A0:5 0.91 þ 0.12 (9) 0.88 þ 0.11 (9)**
Hill coef. 1.01 þ 0.02 (9) 1.01 þ 0.02 (9)
Data are shown as means þ S.E. GS activities are expressed as
nmol/mg/min. FV0:1 (fractional velocity) is expressed as a per-
centage of the ratio of GS activity at 0.1 and 10 mmol/l G6P.
A0:5, activity constant, the concentration in mmol/l that produ-
ces half-maximal activity of GS. Hill coe⁄cient, index of allo-
steric cooperativity of enzyme binding.
*P6 0.05 vs. basal. **P6 0.05 vs. corresponding basal or
stimulated value at normal insulin^glucose. ***P6 0.05 vs. cor-
responding basal or stimulated value at high insulin. 2P6 0.05
vs. corresponding basal or stimulated value at high glucose.
22P = 0.09 vs. corresponding basal value at high insulin. (Mann^
Whitney test).
Table 2
Kinetic parameters of GS at various conditions
Medium (4 days) Basal (1 h) Acute insulin (1 h)
glucose/insulin 5.5 mmol/l/25 pmol/l 5.5 mmol/l/1 Wmol/l
5.5 mmol/l/25 pmol/l
Km0:1 0.53 þ 0.03 (7) 0.38 þ 0.04 (7)*
Vmax0:1 2.76 þ 0.42 (7) 4.03 þ 0.94 (7)
Km10 0.09 þ 0.01 (7) 0.07 þ 0.01 (7)
Vmax10 10.88 þ 1.75 (7) 10.65 þ 1.92 (7)
5.5 mmol/l/1 Wmol/l
Km0:1 0.49 þ 0.03 (6) 0.46 þ 0.03 (7)
Vmax0:1 2.94 þ 0.19 (6) 3.44 þ 0.37 (7)
Km10 0.08 þ 0.01 (6) 0.09 þ 0.01 (7)
Vmax10 10.38 þ 1.13 (6) 12.13 þ 1.17 (7)
20 mmol/l/1 Wmol/l
Km0:1 0.56 þ 0.05 (6) 0.49 þ 0.04 (7)
Vmax0:1 3.29 þ 0.46 (6) 3.27 þ 0.42 (7)
Km10 0.11 þ 0.01 (6) 0.09 þ 0.01 (7)
Vmax10 13.97 þ 1.92 (6) 13.26 þ 1.97 (7)
Data are shown as means þ S.E. Km0:1 and Km10 are Michae-
lis constants measured at 0.1 and 10 mmol/l G6P, expressed as
mmol UDP-glucose. Vmax0:1 and Vmax10 are maximal reaction
velocities at 0.1 and 10 mmol/l G6P, expressed as nmol/mg
(protein)/min.
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concentration required for half-maximal activity of
GS at 0.3 mmol/l UDP-glucose (A0:5 ) and the Hill
coe⁄cient (h) were calculated from GS activities at
the above G6P concentrations ¢tting data to the Hill
equation. The Hill coe⁄cient was de¢ned as the
slope of the line and the A0:5 was determined as
the x-intercept [9].
2.5. Kinetics
For kinetic studies the GS activity was measured
at 0.07, 0.15, 0.31, 0.63, 1.25, 2.5 and 5.0 mmol/l
UDP-glucose in the presence of 0.1 and 10 mmol/l
G6P. The number of cultures studied under each
condition is given in parentheses in Tables 1 and 2.
The Michaelis^Menten constants Km0:1 and Km10
were calculated for 0.1 and 10 mmol/l G6P, respec-
tively, by least-squares ¢t to Hanes plots and ex-
pressed as millimoles UDP-glucose [9]. The maxi-
mum velocities Vmax0:1 and Vmax10 at 0.1 and 10
mmol/l G6P, respectively, were calculated from the
individual curves, and expressed as nanomoles of
UDP-glucose incorporated into glycogen per minute
per milligram of total protein. Initial experiments did
not reveal di¡erences between basal insulin with/
without high glucose; therefore the kinetic parame-
ters were not analysed for the condition of high glu-
cose^basal insulin.
2.6. Glycogen content
Glycogen content was measured in the basal state
of the four culture conditions. Cells were washed
three times with ice-cold PBS and placed in solution
with 0.1 mol/l NaOH. The glycogen content was
measured in accordance with Passonneau and Lowry
[10]. Protein content was measured on aliquots of
extract. Results are expressed as milligrams of glyco-
gen per milligram protein.
2.7. Western blotting
11 Wg total homogenate protein per lane were sep-
arated electrophoretically on SDS^polyacrylamide
gel, and transferred to nitrocellulose membranes.
After blocking, GS immunoreactivity was visualised
by chemiluminescence using GS antibody [11] (a gift
from Dr. H. Vestergaard, Copenhagen, Denmark) as
primary antibody, and quantitated by densitometric
scanning.
2.8. Immunocytochemistry
Immunolabelling of single antigens was performed
using the HRP labelled streptavidin biotin technique
[12]. Primary antibodies were mouse anti-skeletal fast
myosin antibody, clone MY32 (Sigma) and GS anti-
body. Cell cultures were rinsed three times with PBS
and air-dried. Cell cultures were rehydrated with
Tris^HCl bu¡ered saline (TBS) at pH 7.4 and pre-
treated with 2% bovine serum albumin (BSA) in
TBS. Incubation with primary antibodies was carried
out at room temperature for 30 min at the following
dilutions: GS (1/200) and MY32 (1/400). Primary
antibodies were followed by 30 min incubations
with biotinylated secondary antibodies, biotinylated
goat anti-rabbit Ig (Dako, E0432) and biotinylated
goat anti-mouse Ig (Dako E0433), diluted 1/200. In-
cubation with HRP conjugated streptavidin (Dako
P0397) diluted 1/300 was performed for 30 min. 3-
Amino-9-ethylcarbazole (AEC) was used as chromo-
gen. Finally, sections were counter-stained with
Mayers haematoxylin, dehydrated, and mounted
with Aquatex (Merck, Darmstadt, Germany). All di-
lutions of antibodies were done in 1% BSA (Sigma),
and Tris^HCl bu¡ered saline pH 7.4 was used for
rinsing. In control stainings the primary antibodies
were omitted or replaced by primary mouse IgG iso-
type antibodies (Coulter, Miami, FL, USA).
2.9. Statistical analysis
Data in text, tables and ¢gures are given as
mean þ S.E. Statistical analyses were performed
with INSTAT 2.01 (GraphPad, USA). Nonparamet-
ric statistical analyses of data were used: the Mann^
Whitney test for unpaired comparisons and Spear-
man’s rank correlation coe⁄cient b for analysis of
covariance. P6 0.05 was considered signi¢cant.
3. Results
3.1. Cell culture
Phase contrast appearances of human satellite cell
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cultures during proliferation and di¡erentiation are
shown in Fig. 1a,b. Cell cultures were allowed to
di¡erentiate for 4 days before cell cultures were ex-
posed to the di¡erent medium conditions as de-
scribed in Section 2.
3.2. Immunocytochemistry
Immunocytochemical staining of day 8 myotube
cultures for fast heavy chain myosin shows the pres-
ence of multinucleation, longitudinal and cross-stria-
Fig. 1. Phase contrast appearance and fast myosin immunostaining of human satellite cell culture. Human satellite cell cultures were
established, grown and di¡erentiated as described in Section 2. Morphological appearance was investigated by phase contrast micros-
copy. (a) Mononucleated cells during proliferation (U66). (b) Di¡erentiated cultures on day 8 cultured under physiological conditions
(5.0 mmol/l glucose, 25 pmol/l insulin). The cultures contain many multinucleated myo¢bres (U132). (c) Immunocytochemically stain-
ing of day 8 cultures with anti-fast myosin (MY32). Myotubes express cross as well as longitudinal striation (U132). (d) Immunocyto-
chemically staining of day 8 cultures with anti-GS. Myotubes as well as mononucleated cells are immunoreactive for anti-GS (U132).
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tion in myo¢bres (Fig. 1c). In myocytes as well as in
multinucleated myotubes a uniform cytoplasmic GS
immunoreactivity was found (Fig. 1d).
3.3. GS activity
The GS activities in day 8 myotubes exposed to
the various culture conditions described in Section 2
are shown in Table 1. The GS activity was measured
at 0.1 and 10 mmol/l G6P. An increase in G6P from
0.1 to 10 mmol/l signi¢cantly increased the GS activ-
ity in all conditions (not indicated). The basal GS
activities measured at 0.1 and 10 mmol/l G6P were
not signi¢cantly altered by high glucose or high in-
sulin preculture conditions for 4 days. Acute insulin
stimulation signi¢cantly increases the GS activities at
0.1 mmol/l G6P by 30^55% when cells had been ex-
posed for 4 days to normal or high glucose medium
without high insulin.
High glucose preculture conditions for 4 days sig-
ni¢cantly reduced the basal FV0:1 (V20%) compared
to the basal FV0:1 value obtained in normal glucose^
insulin conditions. Basal FV0:1 after exposure to high
glucose^insulin conditions also tended to be lower
(V24%) compared to the normal glucose, high insu-
lin condition (P = 0.09). Acute insulin stimulation
signi¢cantly increased the fractional activity FV0:1
of GS (V50^60%) under normal insulin preculture
conditions whereas under high insulin conditions
acute insulin stimulation failed to induce changes in
FV0:1 (Table 1). High insulin preculture conditions
with or without high glucose signi¢cantly reduced
the insulin stimulated FV0:1 compared to the stimu-
lated FV0:1 obtained in the normal glucose^insulin
condition. Moreover, the stimulated FV0:1 after
high glucose^insulin preculture conditions was signif-
icantly (P6 0.05) reduced compared to the stimu-
lated FV0:1 after high glucose conditions (Table 1).
To further clarify the basis for the absence of acute
insulin stimulation in cultures precultured in high
insulin medium conditions, we investigated the GS
activity per GS protein. Fig. 2 shows the speci¢c
GS activities at 0.1 mmol/l G6P in the basal and
insulin stimulated state. The basal activities in the
four conditions are nearly identical. Acute insulin
stimulation induces an increased GS activity in cell
cultures precultured at low insulin conditions with or
without high glucose (P6 0.05). Moreover, the max-
imal speci¢c GS activities at 10 mmol/l G6P are iden-
tical between the di¡erent culture medium conditions
(Fig. 2B).
3.4. GS kinetics
High glucose normal insulin medium conditions
for 4 days signi¢cantly increased the basal A0:5 com-
pared to the basal A0:5 value under the conditions of
normal glucose^insulin (Table 1). The stimulated A0:5
after exposure to the high glucose^high insulin con-
dition was increased compared to the corresponding
A0:5 value under the conditions of normal glucose^
insulin. Acute insulin stimulation signi¢cantly de-
creased the A0:5 (V25^33%) after exposure to nor-
mal insulin conditions but under high insulin condi-
Fig. 2. E¡ect of the di¡erent experimental conditions on the
speci¢c GS0:1 and GS10 activity in cultures of human myotubes.
Human satellite cell cultures were exposed for 4 days to di¡er-
ent insulin^glucose conditions and the speci¢c GS activities
were determined as described in Section 2. a, basal medium (5.5
mmol/l glucose, 25 pmol/l insulin); b, high insulin medium (5.5
mmol/l glucose, 1 Wmol/l insulin); c, high glucose medium (20
mmol/l glucose, 25 pmol/l insulin); d, high insulin^glucose me-
dium (20 mmol/l glucose, 1 Wmol/l insulin). (A) GS0:1 ; (B)
GS10. Results are shown as means þ S.E. *P6 0.05 vs. corre-
sponding non-stimulated state. 2P6 0.05 vs. corresponding ac-
tivity at 5.5 mmol/glucose and 25 pmol/l insulin.
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tions acute insulin stimulation failed to reduce the
activity constant A0:5 (Table 1).
The Km and Vmax values for UDP-glucose were
measured at 0.1 and 10 mmol/l G6P (Table 2).
When G6P was increased from 0.1 to 10 mmol/l
the Km values in all conditions were signi¢cantly de-
creased (not indicated). Acute insulin stimulation
caused a signi¢cant decrease (V30%) of the Km0:1
under normal insulin preculture conditions but under
high insulin conditions acute insulin stimulation did
not induce signi¢cant changes in Km0:1. The Vmax
values measured at 0.1 and 10 mmol/l G6P were
not signi¢cantly altered by acute or chronic insulin
exposure. The Hill coe⁄cient was approximately 1.0
for all investigated culture conditions.
We found signi¢cant relationships between the in-
dividual fractional activities FV0:1 of GS and Km0:1
(b=30.72, P6 0.0001) (Fig. 3A) and between FV0:1
and A0:5 (b=30.87, P6 0.0001) (Fig. 3B) in the var-
ious medium conditions. Furthermore, a signi¢cant
relationship between individual Km0:1 and A0:5 val-
ues from the di¡erent conditions was found (b= 0.71,
P6 0.0001) (Fig. 3C).
3.5. Glycogen content
Glycogen content was signi¢cantly increased in
cultures exposed to conditions of high glucose (Fig.
4). High insulin conditions per se did not elevate the
glycogen content. The glycogen content was not sig-
ni¢cantly correlated to FV0:1 (b=30.24, P = 0.30),
Km0:1 (b= 0.13, P = 0.58), A0:5 (b= 0.23, P = 0.36).
C
Fig. 3. Relationship between the fractional activity (FV0:1), the
Km0:1 for UDP-glucose and the activity constant A0:5 of GS.
Human satellite cell cultures were exposed for 4 days to three
di¡erent insulin^glucose conditions and the fractional activity
(FV0:1), the corresponding Km0:1 for UDP-glucose and the cor-
responding activity constant A0:5 of GS were determined as de-
scribed in Section 2. The corresponding individual parameters
for the di¡erent conditions of all experiments are plotted. Basal
activities (closed symbols) and acutely insulin stimulated activ-
ities (open symbols) are shown for (A) basal medium (5.5
mmol/l glucose, 25 pmol/l insulin) (E,F), (B) high insulin me-
dium (5.5 mmol/l glucose, 1 Wmol/l insulin) (a,b) and (D) high
insulin^glucose medium (20 mmol/l glucose, 1 Wmol/l insulin)
(8,7). (A) Relationship between the fractional activity (FV0:1)
of GS (x-axis) and the corresponding Km0:1 for UDP-glucose
(y-axis). Spearman’s rank coe⁄cient of correlation b=30.72,
P6 0.0001, n = 39. (B) Relationship between the fractional ac-
tivity (FV0:1) of GS (x-axis) and the corresponding activity con-
stant A0:5 (y-axis). Spearman’s rank coe⁄cient of correlation
b=30.87, P6 0.0001, n = 46. (C) Relationship between the
Km0:1 for UDP-glucose (x-axis) and the corresponding activity
constant A0:5 (y-axis). Spearman’s rank coe⁄cient of correlation
b= 0.71, P = 0.0001, n = 34.
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3.6. GS protein
Western blot analysis of myotube cultures demon-
strated GS immunoreactivity with a band at 84 kDa
(Fig. 5). The di¡erent medium conditions of high
glucose and/or high insulin did not signi¢cantly a¡ect
the protein expression of GS (Ps 0.25) (Fig. 5).
4. Discussion
In this study we have shown that cultured human
myotubes express GS activity and kinetic character-
istics similar to the kinetics known from ‘in vivo’
studies, and that the basal kinetic parameters of
GS are una¡ected by chronic exposure to high insu-
lin and/or glucose. We suggest that insulin induced
insulin resistance of GS is caused by a diminished
decrement of A0:5 and Km0:1 following acute insulin
stimulation.
Insulin resistance in skeletal muscle is associated
with an impaired insulin stimulation of glucose trans-
port and glycogen synthesis [13^15]. The molecular
background and the mechanisms responsible for
these ¢ndings are unclear, and it is still a matter of
debate whether it is a consequence of an adaptive
compensation at the cellular level, or of a direct ex-
pression of a primary genetic trait. In this context
cultures of primary human myotubes o¡er pertinent
characteristics for studies under standardised condi-
tions. Myotubes are metabolically stable from day 4
to day 10 after induction of di¡erentiation, and are
thus at this stage suitable for studies of the e¡ect of
metabolic manipulation [6]. This ensures that all cul-
tures have attained similar cell composition and state
of di¡erentiation, and excludes the potential in£u-
ence of the experimental conditions on the di¡eren-
tiation process [6].
The lack of increase in FV0:1 and in the speci¢c
GS0:1 activity following acute insulin stimulation in
myotubes precultured at high insulin with or without
high glucose but not in myotubes precultured at low
insulin, indicates that insulin induced insulin resis-
tance in human myotubes is introduced at the level
of GS. This is in line with a previous study by Henry
et al. [2] showing that human myotubes cultured at
high insulin express a decreased sensitivity to a sub-
sequent acute insulin stimulation. Glycogen synthase
Fig. 4. E¡ect of the di¡erent experimental conditions on glyco-
gen content in cultures of human myo¢bres. Human satellite
cell cultures were exposed for 4 days to di¡erent insulin^glucose
conditions and the total glycogen content was determined as
described in Section 2. a, basal medium (5.5 mmol/l glucose, 25
pmol/l insulin); b, high insulin medium (5.5 mmol/l glucose,
1 Wmol/l insulin); c, high glucose medium (20 mmol/l glucose,
25 pmol/l insulin); d, high insulin^glucose medium (20 mmol/l
glucose, 1 Wmol/l insulin). Results are shown as means þ S.E.,
n = 8 in each group. *P6 0.008 vs. a; #P6 0.01 vs. b.
Fig. 5. E¡ect of the di¡erent experimental conditions on GS
protein content in cultures of human myo¢bres. Human satellite
cell cultures were exposed for 4 days to di¡erent insulin^glucose
conditions and the GS protein content was determined by
Western blotting as described in Section 2. (Upper panel) Rep-
resentative Western blot of human satellite cell cultures from
the di¡erent conditions. Localisation of molecular weight
markers is shown. (Lower panel) GS protein content in human
myo¢bres cultured in (a) basal medium (5.5 mmol/l glucose, 25
pmol/l insulin); (b) high insulin medium (5.5 mmol/l glucose,
1 Wmol/l insulin); (c) high glucose medium (20 mmol/l glucose,
25 pmol/l insulin); (d) high insulin^glucose medium (20 mmol/l
glucose, 1 W mol/l insulin). Results are shown as means þ S.E.
Ps 0.25, n = 8 in each group.
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activity is covalently modi¢ed by phosphorylation
and dephosphorylation of nine serine residues. In
vitro, the most important GS kinases are glycogen
synthase kinase-3 and cAMP dependent kinase. In-
sulin activates GS either by inhibiting glycogen syn-
thase kinase-3 or by stimulating protein phospha-
tase-1, the principal enzyme dephosphorylating GS.
This is accompanied by a change in GS a⁄nity for
G6P and UDP-glucose. Furthermore, GS activity is
allosterically modi¢ed by G6P. The stimulatory e¡ect
of GS activity by physiological levels of G6P is in-
duced by a conformational change of the phosphor-
ylated form of the GS enzyme, which facilitates its
dephosphorylation.
Glycogen synthase protein levels and speci¢c activ-
ities after maximal activation by G6P were unaf-
fected by the four culture conditions and this implies
a posttranslational mechanism for the regulation of
GS activity. Furthermore, the Hill coe⁄cients of GS
in myotubes precultured under di¡erent metabolic
conditions were comparable, and thus, in accordance
with results from both in vivo [8] and in vitro studies
[2], G6P seems to be the sole [4] allosteric activator
of GS in our cultured myotubes.
Kinetic analyses of the acute insulin stimulation of
GS in cultures precultured at low insulin with or
without high glucose disclose in our study an in-
creased sensitivity of GS to the allosteric activator
G6P (A0:5) and to the substrate uridine diphospho-
glucose (Km0:1), whereas Vmax was unchanged.
Previous studies of cultured human myotubes have
suggested that the kinetics of acute insulin stimula-
tion of GS involve an increased sensitivity to G6P,
an increased Vmax0:1, and an unchanged Km0:1 [2].
However, Km values were not decreased by increas-
ing G6P concentrations (from 0.1 to 10 mmol/l)
[16,17]. The discrepancy between our results and re-
sults from previous studies could be explained by the
fact that in our study the cultures are exposed to
di¡erent metabolic conditions when the myotubes
are metabolically stable and not when satellite cells
are passing through the di¡erentiation process. Our
kinetic analyses are supported by results from in vivo
studies, where the fractional activity of GS in muscle
biopsies from control subjects increases and A0:5 de-
creases following a hyperinsulinaemic, euglycaemic
clamp [5]. The e¡ect of acute insulin stimulation on
glycogen synthase Km has not been assessed previ-
ously in human skeletal muscles. However, animal
studies have shown a reduction in Km0:1 after acute
insulin stimulation and a further reduction as a con-
sequence of increased G6P [16,17]. Taken together, it
is suggested that acute insulin stimulation increases
the fractional activity of GS (FV0:1) by increasing the
sensitivity to the allosteric activator G6P (A0:5) and
its substrate UDP-glucose (Km0:1). We found strong
covariations between the fractional GS activity and
the Km0:1 for UDP-glucose as well as the A0:5, in-
dicating that changes in GS activity are secondary to
changes in Km0:1 or A0:5. This is in line with the
theory since a change in GS fractional velocity at a
¢xed G6P concentration has to be based on a
changed sensitivity for UDP-glucose, either directly
by dephosphorylation of GS or indirectly by a
changed sensitivity to the allosteric e¡ector. The ¢nd-
ing of a linear relationship between Km0:1 and A0:5 is
interesting, and may indicate that the e¡ect of acute
insulin stimulation is mediated through dephosphor-
ylation of sites at GS which are important for both
Km0:1 and A0:5.
A study by Henry et al. [2] shows that human
myotubes precultured at high insulin concentrations
express decreased sensitivity to subsequent acute in-
sulin stimulation. Kinetic analyses suggest a rise in
basal Km0:1 and Vmax0:1 and an unchanged A0:5 as
the underlying mechanism without further changes in
these parameters after acute insulin stimulation [2].
This has been taken to indicate that acquired insulin
resistance is based on (a) increased basal values of
Km0:1 and Vmax0:1 and (b) an abolished e¡ect of
acute insulin on A0:5, Km0:1 and Vmax0:1. In con-
trast, here we describe that myotubes precultured in
medium containing chronic high insulin with or with-
out high glucose were devoid of changes in basal
kinetic parameters (Km0:1, A0:5) but expressed a fail-
ure to decrease A0:5 and Km0:1 following acute in-
sulin stimulation. In vivo studies have shown that the
fractional velocities of basal GS activities were com-
parable in NIDDM and control subjects, and that
FV0:1 increased in both study groups after acute in-
sulin stimulation [5]. Basal A0:5 values were compa-
rable in control subjects and NIDDM patients and
decreased signi¢cantly during a hyperinsulinaemic
clamp [5]. Moreover, the decrement in A0:5 and the
increment in FV0:1 were higher in the control group
compared with the diabetic group [5]. The e¡ect of
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acute and chronic insulin stimulation on Km0:1 of
GS has not been assessed previously in skeletal
muscles from subjects with NIDDM. Chronic high
insulin exposure seems to induce a secondary insulin
resistance characterised by an abolished acute e¡ect
of insulin on kinetic parameters of GS rather than by
an e¡ect on basal kinetic parameters. Insulin induced
insulin resistance at the GS level seems in our hands
to be caused by a failure of acute insulin stimulation
to decrease A0:5 and Km0:1.
The insulin concentration used in the culture me-
dia at ‘high insulin’ conditions in our study is ex-
tremely high. Further studies are needed to clarify
if the same e¡ects would have arisen if the insulin
concentrations used were closer to the physiological
range. What is still unclear, and not dealt with in the
present study, is the issue of the e¡ect of acute in-
sulin stimulation on di¡erent genetic backgrounds, in
particular in ¢rst degree relatives and subjects with
NIDDM. The results from in vivo studies cited
above could indicate that genetic insulin resistance
operates through the same kinetic mechanism as ac-
quired insulin resistance. Dose^response curves of
the e¡ect of chronic insulin exposure on subsequent
insulin stimulation in myotubes established from
control and diabetic subjects may answer this ques-
tion.
Transgenic mice overexpressing glycogen synthase
obtain elevated glycogen levels, indicating that
changes in glycogen synthase levels are important
for glycogen accumulation [18]. We found equal ex-
pression levels of GS protein in the cultures, and thus
a changed expression of GS cannot explain the in-
creased glycogen content in cultures precultured with
high glucose media. Glycogen content has also been
shown to regulate the activity of GS [19] and we
found an increased amount of glycogen under high
glucose conditions. However, we found no signi¢cant
correlation between glycogen content and kinetic pa-
rameters of GS. It could be speculated that the di¡er-
ent preculture conditions do not induce su⁄cient ac-
cumulation of glycogen to down-regulate the activity
of GS. Elsner et al. [20] described that in the rat L6
muscle cell line a highly increased glycogen amount
(U8) only reduces the GS activity to a very low ex-
tent. Thus, our observations of a 25% increase in
glycogen content in myotubes cultured in high com-
pared to normal glucose media would, in extension
of the results from L6 cells, not be expected to induce
changes in GS activity.
In summary, acute insulin stimulation increased
the fractional activity of GS (FV0:1), and increased
its sensitivity to the allosteric activator glucose
6-phosphate (A0:5) and to the substrate uridine di-
phosphoglucose (Km0:1) in human myotube cultures
precultured in medium with low insulin with or with-
out high glucose. Chronic exposure to high insulin
with or without high glucose did not a¡ect the basal
kinetic parameters of the myotubes but abolished
their reactivity to acute insulin stimulation. We sug-
gest that insulin induced insulin resistance of GS is
caused by an abolished reduction of A0:5 and Km0:1
following acute insulin stimulation.
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